The fifth world symposium on pulmonary hypertension

Journal of the American College of Cardiology

Volumn 62, Issue 25 SUPPL., 2013, Pages

  Galiè, Nazzareno ^a   Simonneau, Gerald ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Fifth World Symposium; pulmonary arterial hypertension; pulmonary hypertension

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; ENDOGLIN; ENDOTHELIN RECEPTOR ANTAGONIST; PROSTACYCLIN; SMAD9 PROTEIN; UNCLASSIFIED DRUG;

CLINICAL PRACTICE; CLINICAL RESEARCH; DISEASE CLASSIFICATION; EDITORIAL; ENDARTERECTOMY; EPIDEMIC; HUMAN; LUNG VASCULAR RESISTANCE; MORTALITY; PRIORITY JOURNAL; PUBLICATION; PULMONARY HYPERTENSION; SYMPOSIUM; THROMBOEMBOLISM; WORLD HEALTH ORGANIZATION;

FIFTH WORLD SYMPOSIUM; PULMONARY ARTERIAL HYPERTENSION; PULMONARY HYPERTENSION;

ANTIHYPERTENSIVE AGENTS; FRANCE; HUMANS; HYPERTENSION, PULMONARY; WORLD HEALTH;

EID: 84890749305     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.10.030     Document Type: Review

References (29)

1. R.J. Barst, L.J. Rubin, and W.A. Long A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension: the Primary Pulmonary Hypertension Study Group N Engl J Med 334 1996 296 302
2. E.D. Robin The kingdom of the near-dead: the shortened unnatural life history of primary pulmonary hypertension Chest 92 1987 330 334
3. E. Luthy Proceedings: the epidemic of primary pulmonary hypertension in Europe Pathol Microbiol (Basel) 43 1975 246 247
4. G.E. DAlonzo, R.J. Barst, and S.M. Ayres Survival in patients with primary pulmonary hypertension: results from a national prospective registry Ann Intern Med 115 1991 343 349
5. V.V. McLaughlin, D.E. Genthner, M.M. Panella, and S. Rich Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension N Engl J Med 338 1998 273 277
6. N. Galie, W. Seeger, R. Naeije, G. Simonneau, and L.J. Rubin Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension J Am Coll Cardiol 43 Suppl 2004 S81 S88
7. G. Simonneau, N. Galie, and L.J. Rubin Clinical classification of pulmonary hypertension J Am Coll Cardiol 43 Suppl 2004 S5 S12
8. R. Barst, J. Gibbs, and A. Ghofrani Updated evidence-based treatment algorithm in pulmonary arterial hypertension J Am Coll Cardiol 54 Suppl 2009 S78 S84
9. V.V. McLaughlin, D.B. Badesch, and M. Delcroix End points and clinical trial design in pulmonary arterial hypertension J Am Coll Cardiol 54 Suppl 2009 S97 S107
10. R.M. Tuder, S.L. Archer, and P. Dorfmüller Relevant issues in the pathology and pathobiology of pulmonary hypertension J Am Coll Cardiol 62 Suppl 2013 D4 D12
11. F. Soubrier, W.K. Chung, and R. Machado Genetics and genomics of pulmonary arterial hypertension J Am Coll Cardiol 62 Suppl 2013 D13 D21
12. L. Ma, D. Roman-Campos, and E.D. Austin A novel channelopathy in pulmonary arterial hypertension N Engl J Med 369 2013 351 361
13. A. Vonk-Noordegraaf, F. Haddad, and K.M. Chin Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology J Am Coll Cardiol 62 Suppl 2013 D22 D33
14. G. Simonneau, M.A. Gatzoulis, and I. Adatia Updated clinical classification of pulmonary hypertension J Am Coll Cardiol 62 Suppl 2013 D34 D41
15. M.M. Hoeper, H.J. Bogaard, and R. Condliffe Definitions and diagnosis of pulmonary hypertension J Am Coll Cardiol 62 Suppl 2013 D42 D50
16. M.D. McGoon, R.L. Benza, and P. Escribano-Subias Pulmonary arterial hypertension epidemiology and registries J Am Coll Cardiol 62 Suppl 2013 D51 D59
17. M.M. Hoeper, R.J. Barst, and R.C. Bourge Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study Circulation 127 2013 1128 1138
18. H.A. Ghofrani, N. Galie, and F. Grimminger Riociguat for the treatment of pulmonary arterial hypertension N Engl J Med 369 2013 330 340
19. T. Pulido, I. Adzerikho, and R.N. Channick Macitentan and morbidity and mortality in pulmonary arterial hypertension N Engl J Med 369 2013 809 818
20. M. de Perrot, J.T. Granton, and K. McRae Outcome of patients with pulmonary arterial hypertension referred for lung transplantation: a 14-year single-center experience J Thorac Cardiovasc Surg 143 2012 910 918
21. J.D. Christie, L.B. Edwards, and A.Y. Kucheryavaya The Registry of the International Society for Heart and Lung Transplantation: 29th Adult Lung and Heart-Lung Transplant Report 2012 J Heart Lung Transplant 31 2012 1073 1086
22. N. Galiè, P.A. Corris, and A. Frost Updated treatment algorithm of pulmonary arterial hypertension J Am Coll Cardiol 62 Suppl 2013 D60 D72
23. V.V. McLaughlin, S.P. Gaine, and L.S. Howard Treatment goals of pulmonary hypertension J Am Coll Cardiol 62 Suppl 2013 D73 D81
24. M. Gomberg-Maitland, T.M. Bull, and R. Saggar New trial designs and potential therapies for pulmonary artery hypertension J Am Coll Cardiol 62 Suppl 2013 D82 D91
25. N.H. Kim, M. Delcroix, and D.P. Jenkins Chronic thromboembolic pulmonary hypertension J Am Coll Cardiol 62 Suppl 2013 D92 D99
26. H.A. Ghofrani, A.M. D'Armini, and F. Grimminger Riociguat for the treatment of chronic thromboembolic pulmonary hypertension N Engl J Med 369 2013 319 329
27. J.-L. Vachiery, Y. Adir, and J.A. Barberà Pulmonary hypertension due to left heart diseases J Am Coll Cardiol 62 Suppl 2013 D100 D108
28. W. Seeger, Y. Adir, and J.A. Barberà Pulmonary hypertension in chronic lung diseases J Am Coll Cardiol 62 Suppl 2013 D109 D116
29. D.D. Ivy, S.H. Abman, and R.J. Barst Pediatric pulmonary hypertension J Am Coll Cardiol 62 Suppl 2013 D117 D126